Collection

VPAG 2024: scheme documents and guidance

Publications covering the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG), a voluntary agreement between DHSC, NHS England and ABPI.

• From: Department of Health and Social Care
• Published: 7 August 2025

This collection brings together the following VPAG publications:

• summary of the heads of agreement: the terms of the agreement reached between the Department of Health and Social Care (DHSC), NHS England and the Association of the British Pharmaceutical Industry (ABPI) for a new voluntary scheme
• the full VPAG agreement
• the annual payment percentage, which sets out the payment due from members of VPAG
• decisions of the VPAG dispute resolution panel

There are separate collections on:

• VPAG operational review minutes (minutes of meetings held between the government, NHS England and ABPI about how VPAG is operating)
• VPAG quarterly net sales and payment information

Summary of the heads of agreement

• 2024 voluntary scheme for branded medicines pricing, access and growth: summary of the heads of agreement
  • 20 November 2023
  • Policy paper

Full VPAG agreement

• 2024 voluntary scheme for branded medicines pricing, access and growth
  • 14 December 2023
  • Policy paper

Payment percentage for 2025

• The 2024 voluntary scheme for branded medicines pricing, access and growth: payment percentage for 2025
  • 16 December 2024
  • Guidance

Dispute resolution panel decisions

• VPAG dispute resolution panel, June 2025: DHSC and Haleon UK Ltd
  • 7 August 2025
  • Decision
• VPAG dispute resolution panel, February 2025: DHSC and B. Braun
  • 27 March 2025
  • Decision

Published 7 August 2025